Kontafarma China Holdings Ltd (HK:1312) has released an update.
Kontafarma China Holdings Ltd announced the successful adoption of all proposed resolutions at its Annual General Meeting on June 7, 2024, with overwhelming shareholder approval. Key decisions included the re-election and appointment of board members, authorization for directors’ fee fixation, re-appointment of the independent auditor, and the granting of mandates for securities issuance and share buyback.
For further insights into HK:1312 stock, check out TipRanks’ Stock Analysis page.
